Investors with horizon of 6-12 months can consider following scripts for their investment. These companies have potential to give higher returns than index over a long term.

Corporate Highlights - Drug firm Aurobindo Pharma has received final approval from the US health regulator to market Famciclovir tablets, used for treating herpes simplex infections in HIV-infected patients, in the American market. The company's tentatively approved abbreviated new drug approval (ANDA) for Famciclovir tablets in 125 mg, 250 mg and 500 mg strengths has received final approval from the US Food and Drug Administration.

• Nestle India, the fast moving consumer goods company, inaugurated new manufacturing plant at Nanjangud in Mysore district, about 170 kms from here. The company has invested Rs 360 crore to set up the new plant, which will manufacture a range of culinary products starting from noodles.

• Glenmark Pharmaceuticals US-based unit has received final approval from the US health regulator to market a generic oral contraceptive drug, 'Briellyn', in the American market. The company's US-based arm, Glenmark Generics Inc, has got final approval for its abbreviated new drug application (ANDA) for Norethindrone and Ethinyl Estradiol, USP 0.4 mg/0.035 mg tablets, from the United States Food and Drug Administration.

Economic Highlights

The government approved 14 proposals of foreign direct investment (FDI), including that of Mauritius-based Ghir Investments, totalling Rs 1,289.85 crore. The Foreign Investment Promotion Board (FIPB), however, deferred decisions on 27 proposals, including that of Essar Capital Holdings and Forbo Holding AG, Lindenstrasse, Switzerland.